Search Results - "Dores, Graça M"

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World by Kamangar, Farin, Dores, Graça M, Anderson, William F

“…Efforts to reduce global cancer disparities begin with an understanding of geographic patterns in cancer incidence, mortality, and prevalence. Using the…”
Get full text

T-Cell Neoplasms after B-Cell Neoplasms — The Pre–CAR T-Cell Era by Dores, Graça M., Morton, Lindsay M.

“…T-cell neoplasms after treatment for B-cell neoplasms are not unique to CAR T-cell therapy. In the pre–CAR T-cell era, the risk of a T-cell neoplasm after…”
Get full text

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007 by Dores, Graça M., Devesa, Susan S., Curtis, Rochelle E., Linet, Martha S., Morton, Lindsay M.

“…Since 2001, the World Health Organization classification for hematopoietic and lymphoid neoplasms has provided a framework for defining acute leukemia (AL)…”
Get full text

The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma by Chihara, Dai, Dores, Graça M., Flowers, Christopher R., Morton, Lindsay M.

“…Lymphoma survivors have a significantly higher risk of developing second primary lymphoma than the general population; however, bidirectional risks of…”
Get full text

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008 by Morton, Lindsay M., Dores, Graça M., Tucker, Margaret A., Kim, Clara J., Onel, Kenan, Gilbert, Ethel S., Fraumeni, Joseph F., Curtis, Rochelle E.

“…Therapy-related acute myeloid leukemia (tAML) is a rare but highly fatal complication of cytotoxic chemotherapy. Despite major changes in cancer treatment,…”
Get full text

Incidence of Carcinoma of the Major Salivary Glands According to the WHO Classification, 1992 to 2006: A Population-Based Study in the United States by BOUKHERIS, Houda, CURTIS, Rochelle E, LAND, Charles E, DORES, Graça M

“…Background: Carcinomas of the major salivary glands (M-SGC) comprise a morphologically diverse group of rare tumors of largely unknown cause. To gain insight…”
Get full text

Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016 by Dores, Graça M, Curtis, Rochelle E, Dalal, Nicole H, Linet, Martha S, Morton, Lindsay M

“…Mortality for patients with classical Hodgkin lymphoma (cHL) treated during an era characterized in the United States by widespread use of doxorubicin,…”
Get full text

Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database by Saunders-Hastings, Patrick, Heong, Sze Wing, Srichaikul, Jenny, Wong, Hui-Lee, Shoaibi, Azadeh, Chada, Kinnera, Burrell, Timothy A, Dores, Graça M

“…Background Healthcare administrative claims data hold value for monitoring drug safety and assessing drug effectiveness. The U.S. Food and Drug Administration…”
Get full text

Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia by Dores, Graça M., Linet, Martha S., Curtis, Rochelle E., Morton, Lindsay M.

Get full text

Changes in sex-specific incidence of lymphoid neoplasms across the lifespan by Valcarcel, Bryan, Schonfeld, Sara J, Jackson, Sarah S, Dores, Graça M, Linet, Martha S, Morton, Lindsay M

Get full text

Uncovering the Genetic Etiology of the (Posttherapy) Broken Heart by Linet, Martha S, Dores, Graça M, Savage, Sharon A

Get full text

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004 by Dores, Graça M., Landgren, Ola, McGlynn, Katherine A., Curtis, Rochelle E., Linet, Martha S., Devesa, Susan S.

“…Summary Population‐based plasmacytoma incidence and survival data are sparse. We analyzed incidence rates (IRs), IR ratios (IRRs), and 5‐year relative survival…”
Get full text

Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017 by Su, John R., Haber, Penina, Ng, Carmen S., Marquez, Paige L., Dores, Graça M., Perez-Vilar, Silvia, Cano, Maria V.

“…•VAERS received 1086 reports of EM/SJS/TEN during 1999–2017, mostly EM (984, 91%).•Most reports of SJS or TEN (52–100%), but few reports of EM (9%), were…”
Get full text

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System by Dores, Graça M., Nayernama, Afrouz, Cheng, Connie, Moureaud, Charlotte, Jones, S. Christopher

Get full text

Comparison of Age Distribution Patterns for Different Histopathologic Types of Breast Carcinoma by ANDERSON, William F, PFEIFFER, Ruth M, DORES, Graca M, SHERMAN, Mark E

“…Background: Historically, female breast carcinoma has been viewed as an etiologically homogeneous disease associated with rapidly increasing incidence rates…”
Get full text

Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era by Morton, Lindsay M, Dores, Graça M, Schonfeld, Sara J, Linet, Martha S, Sigel, Byron S, Lam, Clara J K, Tucker, Margaret A, Curtis, Rochelle E

“…Therapy-related myelodysplastic syndrome or acute myeloid leukemia (tMDS/AML) is a rare, usually fatal complication of chemotherapy, including certain…”
Get more information

Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017 by Dores, Graça M., Curtis, Rochelle E., Linet, Martha S., Morton, Lindsay M.

Get full text

U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome by Kaland, David A., Dores, Graça M., Nayernama, Afrouz, Camilli, Sara

“…•Lurbinectedin is an intravenous alkylating drug approved by the U.S. Food and Drug Administration (FDA) under accelerated approval on June 15, 2020, for the…”
Get full text

Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site by Khalil, Mohammad O., Morton, Lindsay M., Devesa, Susan S., Check, David P., Curtis, Rochelle E., Weisenburger, Dennis D., Dores, Graça M.

“…Summary The aetiology of marginal zone lymphoma (MZL) is purported to differ by anatomic site. While this is supported by clinical series of single MZL sites,…”
Get full text

Merkel Cell Carcinoma and Multiple Primary Cancers by HOWARD, Regan A, DORES, Graca M, CURTIS, Rochelle E, ANDERSON, William F, TRAVIS, Lois B

“…Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumor of the skin for which causative factors remain largely unknown. The site-specific risks of…”
Get full text